{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:17:11Z","timestamp":1792088231856,"version":"4.4.0"},"reference-count":40,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.2217\/pgs-2021-0080","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T08:40:52Z","timestamp":1639644052000},"page":"97-118","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Association of\n            <i>NAT-2<\/i>\n            Gene Polymorphisms Toward Lung Cancer Susceptibility and Prognosis in North Indian Patients Treated with Platinum-Based Chemotherapy"],"prefix":"10.1080","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6844-6218","authenticated-orcid":false,"given":"Harleen Kaur","family":"Walia","sequence":"first","affiliation":[{"name":"Department of Biotechnology, Thapar Institute of Engineering &amp; Technology, Patiala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5403-0721","authenticated-orcid":false,"given":"Navneet","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Post Graduate Institute of Medical Education &amp; Research (PGIMER), Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9414-3771","authenticated-orcid":false,"given":"Siddharth","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Thapar Institute of Engineering &amp; Technology, Patiala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,12,16]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1155\/2006\/436497"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgm021"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-014-1868-z"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0090-9"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001947"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-7-58"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/20.9.1877"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1415-47572012005000074"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v17.i6.760"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199508000-00004"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199808000-00002"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200003000-00010"},{"issue":"17","key":"e_1_3_4_15_1","first-page":"3961","article-title":"Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer","volume":"56","author":"Cascorbi I","year":"1996","unstructured":"Cascorbi I , Brockm\u00f6llerJ , MrozikiewizPM , BauerS , LoddenkemperR , RootsI. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cancer Res.56(17), 3961\u20133966 (1996).","journal-title":"Cancer Res."},{"issue":"1","key":"e_1_3_4_16_1","first-page":"577","article-title":"N-acetylation polymorphism in patients with lung cancer and its association with p53 gene mutation","volume":"17","author":"Oyama T","year":"1997","unstructured":"Oyama T , KawamotoT , MizoueT , YasumotoK , KodamaY , MitsudomiT. N-acetylation polymorphism in patients with lung cancer and its association with p53 gene mutation. Anticancer Res.17(1B), 577\u2013581 (1997).","journal-title":"Anticancer Res."},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/21.1.49"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2010.12.012"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2008.0797"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317695533"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.34.9.758"},{"issue":"11","key":"e_1_3_4_22_1","first-page":"530","article-title":"Cytochrome P450 (CYP450, 2D6* A), N-acetyltransferase-2 (NAT2* 7, A) and multidrug resistance 1 (MDR1 3435 T) alleles collectively increase risk of ulcerative colitis","volume":"21","author":"Lotfi F","year":"2018","unstructured":"Lotfi F , BahrehmandF , Vaisi-RayganiAet al. Cytochrome P450 (CYP450, 2D6* A), N-acetyltransferase-2 (NAT2* 7, A) and multidrug resistance 1 (MDR1 3435 T) alleles collectively increase risk of ulcerative colitis. Arch. Iran. Med.21(11), 530\u2013535 (2018).","journal-title":"Arch. Iran. Med."},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2008.07.001"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1101\/sqb.2001.66.33"},{"issue":"1","key":"e_1_3_4_25_1","first-page":"15","article-title":"Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer","volume":"11","author":"Zhou W","year":"2002","unstructured":"Zhou W , LiuG , ThurstonSWet al. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Cancer Epidemiol. Biomark. Prev.11(1), 15\u201321 (2002).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-05-0691"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200103000-00006"},{"issue":"4","key":"e_1_3_4_28_1","first-page":"350","article-title":"Role of gene polymorphisms of phase II of xenobiotic biotransformation from glutathione-S-transferase and N-acetyltransferase families in susceptibility to lung cancer among Mayak workers","volume":"54","author":"Rusinova GG","year":"2014","unstructured":"Rusinova GG , AzizovaTV , ViazovskaiaNS , GlazkovaIV , OsovetsSV. Role of gene polymorphisms of phase II of xenobiotic biotransformation from glutathione-S-transferase and N-acetyltransferase families in susceptibility to lung cancer among Mayak workers. Radiatsionnaia Biologiia Radioecologiia.54(4), 350\u2013359 (2014).","journal-title":"Radiatsionnaia Biologiia Radioecologiia."},{"key":"e_1_3_4_29_1","doi-asserted-by":"crossref","unstructured":"Zhu K XuA ZhangBet al. Effects of NAT2 polymorphism on lung cancer risk and the interaction between smoking and NAT2: a meta-analysis (2020). https:\/\/www.researchsquare.com\/article\/rs-39646\/v1","DOI":"10.21203\/rs.3.rs-39646\/v1"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7086"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-0553"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/22.4.673"},{"issue":"5","key":"e_1_3_4_33_1","first-page":"364","article-title":"A pilot study testing the genetic polymorphism of N-acetyltransferase 2 as a risk factor in lung cancer","volume":"52","author":"Habalova V","year":"2005","unstructured":"Habalova V , SalagovicJ , KalinaI , StubnaJ. A pilot study testing the genetic polymorphism of N-acetyltransferase 2 as a risk factor in lung cancer. Neoplasma52(5), 364\u2013368 (2005).","journal-title":"Neoplasma"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgn020"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2004.10.013"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2004.12.015"},{"key":"e_1_3_4_37_1","first-page":"11","article-title":"Association between NAT2 polymorphism and lung cancer risk: a systematic review and meta-analysis","author":"Zhu K","year":"2021","unstructured":"Zhu K , XuA , XiaWet al. Association between NAT2 polymorphism and lung cancer risk: a systematic review and meta-analysis. Front. Oncol.11 (2021).","journal-title":"Front. Oncol."},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2004.11.012"},{"issue":"1","key":"e_1_3_4_39_1","first-page":"103","article-title":"NAT2 and CYP1A2 Polymorphisms and Lung Cancer Risk in Relation to Smoking Status","volume":"8","author":"Osawa Y","year":"2007","unstructured":"Osawa Y , OsawaK , MiyaishiAet al. NAT2 and CYP1A2 Polymorphisms and Lung Cancer Risk in Relation to Smoking Status. Asian Pac. J. Cancer Prev.8(1), 103\u2013108 (2007).","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"10","key":"e_1_3_4_40_1","first-page":"875","article-title":"Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls","volume":"7","author":"Nyberg F","year":"1998","unstructured":"Nyberg F , HouSM , HemminkiK , LambertB , PershagenG. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls. Cancer Epidemiol. Biomark. Prev.7(10), 875\u2013883 (1998).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2014.15.21.9203"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/18.11.2127"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs-2021-0080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T12:54:42Z","timestamp":1715950482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs-2021-0080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,16]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.2217\/pgs-2021-0080"],"URL":"https:\/\/doi.org\/10.2217\/pgs-2021-0080","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-06-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}